Perlecan Domain-V Enhances Neurogenic Brain Repair After Stroke in Mice
Open Access
- 7 April 2020
- journal article
- research article
- Published by Springer Nature in Translational Stroke Research
- Vol. 12 (1) , 72-86
Abstract
The extracellular matrix fragment perlecan domain V is neuroprotective and functionally restorative following experimental stroke. As neurogenesis is an important component of chronic post-stroke repair, and previous studies have implicated perlecan in developmental neurogenesis, we hypothesized that domain V could have a broad therapeutic window by enhancing neurogenesis after stroke. We demonstrated that domain V is chronically increased in the brains of human stroke patients, suggesting that it is present during post-stroke neurogenic periods. Furthermore, perlecan deficient mice had significantly less neuroblast precursor cells after experimental stroke. Seven-day delayed domain V administration enhanced neurogenesis and restored peri-infarct excitatory synaptic drive to neocortical layer 2/3 pyramidal neurons after experimental stroke. Domain V’s effects were inhibited by blockade of α2β1 integrin, suggesting the importance of α2β1 integrin to neurogenesis and domain V neurogenic effects. Our results demonstrate that perlecan plays a previously unrecognized role in post-stroke neurogenesis and that delayed DV administration after experimental stroke enhances neurogenesis and improves recovery in an α2β1 integrin-mediated fashion. We conclude that domain V is a clinically relevant neuroprotective and neuroreparative novel stroke therapy with a broad therapeutic window.Keywords
Funding Information
- National Institutes of Health (R21 NS079960, R21 NS088608, R01 NS092552)
- American Heart Association (Predoctoral)
- Sir Charles Hercus Fellowship from the Health Research Council of New Zealand (NA)
- Health Research Council of New Zealand (NA)
- Royal Society of New Zealand Marsden Fund (NA)
- Neurological Foundation of New Zealand (NA)
This publication has 48 references indexed in Scilit:
- Perlecan Domain V Induces VEGf Secretion in Brain Endothelial Cells through Integrin α5β1 and ERK-Dependent Signaling PathwaysPLOS ONE, 2012
- A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after strokeProceedings of the National Academy of Sciences, 2012
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodentsJournal of Clinical Investigation, 2011
- Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after strokeNature, 2010
- Integrin Signaling Switches the Cytoskeletal and Exocytic Machinery that Drives NeuritogenesisDevelopmental Cell, 2010
- Enhanced Infragranular and Supragranular Synaptic Input onto Layer 5 Pyramidal Neurons in a Rat Model of Cortical DysplasiaCerebral Cortex, 2010
- Human Neurospheres as Three-Dimensional Cellular Systems for Developmental Neurotoxicity TestingEnvironmental Health Perspectives, 2009
- Perlecan controls neurogenesis in the developing telencephalonBMC Developmental Biology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001